-
ANIX Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Anixa Biosciences (ANIX)
Company Profile
Quarter (USD) | Jul 24 | Apr 24 | Jan 24 | Oct 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Oct 23 | Oct 22 | Oct 21 | Oct 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 1.23 mm | 1.23 mm | 1.23 mm | 1.23 mm | 1.23 mm | 1.23 mm |
Cash burn (monthly) | (no burn) | 164.42 k | 1.20 mm | 1.14 mm | 881.00 k | 698.08 k |
Cash used (since last report) | n/a | 782.08 k | 5.70 mm | 5.44 mm | 4.19 mm | 3.32 mm |
Cash remaining | n/a | 442.92 k | -4.47 mm | -4.21 mm | -2.97 mm | -2.10 mm |
Runway (months of cash) | n/a | 2.7 | -3.7 | -3.7 | -3.4 | -3.0 |
13F holders | Current |
---|---|
Total holders | 44 |
Opened positions | 11 |
Closed positions | 12 |
Increased positions | 14 |
Reduced positions | 5 |
13F shares | Current |
---|---|
Total value | 14.68 bn |
Total shares | 4.82 mm |
Total puts | 20.20 k |
Total calls | 0.00 |
Total put/call ratio | Infinity |
Largest owners | Shares | Value |
---|---|---|
Vanguard | 1.39 mm | $4.35 bn |
Laird Norton Trust | 604.24 k | $1.89 bn |
UBS UBS | 536.31 k | $1.67 bn |
Mission Wealth Management | 502.42 k | $1.57 bn |
Susquehanna International | 340.95 k | $1.06 bn |
Geode Capital Management | 320.15 k | $999.11 mm |
Long Focus Capital Management | 165.70 k | $516.99 mm |
BLK BlackRock | 154.66 k | $482.55 mm |
STT State Street | 108.50 k | $338.52 mm |
Qube Research & Technologies | 93.34 k | $291.23 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
22 Oct 24 | Titterton Lewis H jr | Common Stock | Option exercise | Acquire M | No | No | 2.575 | 16,000 | 41.20 k | 912,334 |
22 Oct 24 | Titterton Lewis H jr | Employee Stock Option Common Stock | Option exercise | Dispose M | No | No | 2.575 | 16,000 | 41.20 k | 0 |
31 Jul 24 | Titterton Lewis H jr | Common Stock | Buy | Acquire P | No | No | 3.23 | 5,580 | 18.02 k | 896,334 |
30 Jul 24 | Titterton Lewis H jr | Common Stock | Buy | Acquire P | No | No | 3.06 | 21,646 | 66.24 k | 890,754 |
26 Jul 24 | Baskies Arnold M | Common Stock | Buy | Acquire P | No | No | 3.09 | 5,000 | 15.45 k | 115,000 |
26 Jul 24 | Titterton Lewis H jr | Common Stock | Buy | Acquire P | No | No | 3.03 | 7,700 | 23.33 k | 869,108 |
25 Jul 24 | Titterton Lewis H jr | Common Stock | Buy | Acquire P | No | No | 2.81 | 796 | 2.24 k | 861,408 |
14 Jun 24 | Titterton Lewis H jr | Common Stock | Buy | Acquire P | No | No | 2.68 | 4,000 | 10.72 k | 860,612 |